Procedures of sampling and measurements. by Xuegang Mao (599968)

Introduction status of PCVs in European countries over time. by Heloisa Ricci Conesa (18291210)

Data extraction grid. by Heloisa Ricci Conesa (18291210)

“…No homogenous trends were identified in incidence rates across countries, or in detection of S. pneumoniae as a cause of AOM over time. There were indications of a reduction in hospitalization rates (decreases between 24.5–38.8% points, depending on country, PCV type and time since PCV introduction) and antibiotic resistance (decreases between 14–24%, depending on country), following the widespread use of PCVs over time. …”

Incidence rates of AOM cases. by Heloisa Ricci Conesa (18291210)

“…No homogenous trends were identified in incidence rates across countries, or in detection of S. pneumoniae as a cause of AOM over time. There were indications of a reduction in hospitalization rates (decreases between 24.5–38.8% points, depending on country, PCV type and time since PCV introduction) and antibiotic resistance (decreases between 14–24%, depending on country), following the widespread use of PCVs over time. …”

Inclusion criteria. by Heloisa Ricci Conesa (18291210)

“…No homogenous trends were identified in incidence rates across countries, or in detection of S. pneumoniae as a cause of AOM over time. There were indications of a reduction in hospitalization rates (decreases between 24.5–38.8% points, depending on country, PCV type and time since PCV introduction) and antibiotic resistance (decreases between 14–24%, depending on country), following the widespread use of PCVs over time. …”

PRISMA flow diagram for the literature search. by Heloisa Ricci Conesa (18291210)

“…No homogenous trends were identified in incidence rates across countries, or in detection of S. pneumoniae as a cause of AOM over time. There were indications of a reduction in hospitalization rates (decreases between 24.5–38.8% points, depending on country, PCV type and time since PCV introduction) and antibiotic resistance (decreases between 14–24%, depending on country), following the widespread use of PCVs over time. …”

Estimates for direct medical and total costs per AOM episode (2020 EUR), by country [35, 96–100]. by Heloisa Ricci Conesa (18291210)

Vertical distributions in the three field settings. by Xuegang Mao (599968)

Fig 5 - by Kellie J. Walters (10451329)

Heterocene Catalysts and Reaction Temperature Gradient in Dec-1-ene Oligomerization for the Production of Low Viscosity PAO Base Stocks by Ilya E. Nifant’ev (1561813)

“…A gradual decrease of the oligomerization temperature as dec-1-ene was consumed resulted in decreased dimer formation (down to 10%) and increased oligomer yields (up to 84%). …”

<i>prx-5/6</i> mutations likely cause a decrease in mmBCFA degradation. by Rencheng Wang (463927)

“…<i>elo-5</i>(<i>lf</i>)<i>; Ex</i>[<i>elo-6</i>] is a transgenic strain that significantly overexpressed the <i>elo-6</i> gene and was not sufficient to suppress the L1 arrest phenotype of <i>elo-5</i>(<i>lf</i>). …”

HAstV-1 infection leads to a decrease in epithelial markers while increasing mesenchymal markers. by Virginia Hargest (12447014)

CYP3A94 activity is significantly increased in V79-CYP3A94/DD-POR cells, but decreases after incubation with Shield-1. by Ramona Dettwiler (664360)

The peak energies of the fits of individual measured V Kβ spectra by C T Chantler (557430)

“…The peak energy of the titanium Kβ spectral profile is found to be 4931.966 ± 0.022 eV prior to instrumental broadening. This 4.5 ppm result decreases the uncertainty over the past literature by a factor of 2.6 and is 2.4 standard deviations from the previous standard. …”

Gut richness and diversity decrease significantly by week 5 of chemoradiotherapy. by Molly B. El Alam (10231830)

The effect of STOX1A on cell proliferation in the neuroblastoma cell-line SH-SY5Y. by Daan van Abel (214754)

“…<p>(A) The proliferation curve shows significantly decreased cell proliferation for STOX1A siRNA transfected SH-SY5Y cells compared to scrambled controls after 1, 2, and 3 days in culture. …”

5S rDNA transgenes show preferential association with the nucleolus and decreased transcription of a reporter gene. by Andrew M. Fedoriw (187310)

BoNT/A (3.5 U/kg) decreases orofacial formalin-induced dural extravasation. by Boris Filipović (336089)

Differentially regulated genes in cells with increased or decreased expression of miR-106a-5p. by Feng Zhi (294362)

“…(C) A Venn diagram of the overlap of altered genes with increased or decreased miR-106a-5p expression. …”

Mean decrease in visual analogue scale for dyspnea based on different procedures. by Eleanor K. Mishra (724106)